INVO Fertility, Inc.
IVF · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.14 | -0.52 | 4.34 |
| FCF Yield | -104.97% | -10.81% | -2.68% | -0.38% |
| EV / EBITDA | -1.70 | -7.87 | -23.14 | -324.97 |
| Quality | ||||
| ROIC | -23.09% | -55.69% | -821.03% | -55.33% |
| Gross Margin | 44.00% | 35.96% | -3.48% | 96.51% |
| Cash Conversion Ratio | 0.33 | 0.59 | 0.61 | 0.91 |
| Growth | ||||
| Revenue 3-Year CAGR | 99.54% | -10.12% | -7.45% | 41.12% |
| Free Cash Flow Growth | 39.26% | 21.41% | -2.03% | -33.32% |
| Safety | ||||
| Net Debt / EBITDA | -1.28 | -0.88 | -0.20 | 0.68 |
| Interest Coverage | -7.69 | -7.31 | -178.76 | -4.12 |
| Efficiency | ||||
| Inventory Turnover | 16.64 | 7.31 | 3.23 | 0.50 |
| Cash Conversion Cycle | -538.48 | -372.82 | -431.43 | -387.24 |